Quick Answer
HAEMONETICS CORP reported Research And Development Expense of $62.72 million for the year ending 2025.
- HAEMONETICS CORP showed an increase of +15.2% in Research And Development Expense from 2024 to 2025.
- This data is from HAEMONETICS CORP's annual report (Form 10-K), filed with the SEC on May 21, 2025.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2009: $6.46 million | Q2 2010: $7.92 million | Q3 2010: $7.95 million | Q4 2010: $8.00 million | Q2 2011: $8.61 million | Q3 2011: $10.35 million | Q4 2011: $9.23 million | Q2 2012: $9.41 million | Q3 2012: $10.83 million | Q4 2012: $10.59 million | Q2 2013: $11.21 million | Q3 2013: $14.95 million | Q4 2013: $14.21 million | Q2 2014: $15.38 million | Q3 2014: $10.94 million | Q4 2014: $10.64 million | Q2 2015: $11.32 million | Q3 2015: $11.55 million | Q4 2015: $10.94 million | Q2 2016: $11.44 million | Q3 2016: $8.34 million | Q4 2016: $8.46 million | Q2 2017: $8.19 million | Q3 2017: $7.52 million | Q4 2017: $12.43 million | Q2 2018: $9.41 million | Q3 2018: $8.58 million | Q4 2018: $8.98 million | Q2 2019: $7.49 million | Q3 2019: $7.42 million | Q4 2019: $7.00 million | Q2 2020: $7.75 million | Q3 2020: $6.76 million | Q4 2020: $7.50 million | Q2 2021: $12.70 million | Q3 2021: $10.85 million | Q4 2021: $10.04 million | Q2 2022: $10.90 million | Q3 2022: $10.90 million | Q4 2022: $12.69 million | Q2 2023: $12.65 million | Q3 2023: $12.67 million | Q4 2023: $13.27 million | Q2 2024: $14.45 million | Q3 2024: $14.14 million | Q4 2024: $15.83 million | Q2 2025: $16.26 million | Q3 2025: $14.87 million | Q4 2025: $14.19 million.
- Over the full 17 years of available data (2009 to 2025), HAEMONETICS CORP's Research And Development Expense has grown by 162.9%.
- Historical annual values: Fiscal year 2025: $62.72 million | Fiscal year 2024: $54.44 million | Fiscal year 2023: $50.13 million | Fiscal year 2022: $46.80 million | Fiscal year 2021: $32.86 million | Fiscal year 2020: $30.88 million | Fiscal year 2019: $35.71 million | Fiscal year 2018: $39.23 million | Fiscal year 2017: $37.56 million | Fiscal year 2016: $44.97 million | Fiscal year 2015: $54.19 million | Fiscal year 2014: $54.20 million | Fiscal year 2013: $44.39 million | Fiscal year 2012: $36.80 million | Fiscal year 2011: $32.66 million | Fiscal year 2010: $26.38 million | Fiscal year 2009: $23.86 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: